SNAI2 and invasive breast carcinoma: In the invasive breast cancer subset, tumors with the highest expression of SNAI2 had a significantly poorer likelihood of progression-free survival (Supplementary Figure S2A), and high SNAI2-expressing tumors were enriched significantly in the claudin-low subtype (Supplementary Figure S2B).